Piramal Pharma

Piramal Pharma Limited has informed the Exchange regarding Mr. Subramanian Ramadorai cessation as an Independent Director of the Company with effect from 9th February, 2026

05 Feb, 2026 | 11:22am • Source: NSE

Please see intimation of completion of term of Independent Director, Mr. Subramanian Ramadorai.

05 Feb, 2026 | 10:31am • Source: BSE

Audio Recording of Conference Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 31st December, 2025

29 Jan, 2026 | 04:52pm • Source: BSE

Piramal Pharma Limited has informed the Exchange regarding appointment of Ms. Pratibha Mishra as Company Secretary & Compliance Officer of the Company w.e.f. February 21,...

29 Jan, 2026 | 10:53am • Source: NSE

Piramal Pharma Limited has informed the Exchange regarding a press release dated January 28, 2026, titled "Piramal Pharma Limited Announces Results for Q3 and 9M...

29 Jan, 2026 | 10:50am • Source: NSE

Changes in Senior Management Personnel ( SMP ) and Key Managerial Personnel ( KMP ) of the Company

29 Jan, 2026 | 10:49am • Source: NSE

Please see enclosed disclosure of E-voting Results and Scrutinizer''s Report on the Postal Ballot

16 Jan, 2026 | 09:45pm • Source: BSE

Pursuant to Regulation 30(6) of the SEBI Listing Regulations, please find enclosed herewith the details of the Conference Call with investors/ analysts.

16 Jan, 2026 | 12:21pm • Source: BSE

Piramal Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/01/2026 ,inter alia, to consider and...

16 Jan, 2026 | 12:18pm • Source: BSE

Submission of copy of newspaper advertisement for Postal Ballot

18 Dec, 2025 | 02:36pm • Source: BSE

Please find enclosed Postal Ballot Notice intimation.

17 Dec, 2025 | 03:11pm • Source: BSE

Please find enclosed intimation of appointment of Independent Director.

08 Dec, 2025 | 06:12pm • Source: BSE

Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

19 Nov, 2025 | 04:48pm • Source: BSE

Please see enclosed Transcript of Conference Call on the Unaudited Financial Results (Standalone & Consolidated) for the quarter ended September 30, 2025

07 Nov, 2025 | 03:13pm • Source: BSE

Audio Recording of Conference Call on the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th September, 2025

06 Nov, 2025 | 12:26pm • Source: BSE

Please see enclosed Investor Presentation - Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended September 30, 2025

05 Nov, 2025 | 09:05pm • Source: BSE

Please see enclosed Press Release - Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter and half year ended September 30, 2025

05 Nov, 2025 | 09:02pm • Source: BSE

Please find enclosed Unaudited Financial Results (Standalone & Consolidated) for quarter ended September 30, 2025

05 Nov, 2025 | 09:00pm • Source: BSE

Please find enclosed outcome of Board Meeting held on November 5, 2025

05 Nov, 2025 | 08:55pm • Source: BSE

Intimation of Schedule of Analyst/ Institutional Investor Meetings under the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015

03 Nov, 2025 | 05:25pm • Source: BSE